M
Marc J.M. Bonten
Researcher at Utrecht University
Publications - 53
Citations - 4633
Marc J.M. Bonten is an academic researcher from Utrecht University. The author has contributed to research in topics: Intensive care & Sepsis. The author has an hindex of 21, co-authored 53 publications receiving 3089 citations. Previous affiliations of Marc J.M. Bonten include University Medical Center Utrecht & Oklahoma State University Center for Health Sciences.
Papers
More filters
Journal ArticleDOI
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
Laure Wynants,Laure Wynants,Ben Van Calster,Ben Van Calster,Gary S. Collins,Gary S. Collins,Richard D Riley,Georg Heinze,Ewoud Schuit,Marc J.M. Bonten,Darren Dahly,Johanna A A G Damen,Thomas P. A. Debray,Valentijn M.T. de Jong,Maarten De Vos,Paula Dhiman,Paula Dhiman,Maria C Haller,Michael O. Harhay,Liesbet Henckaerts,Pauline Heus,Michael Kammer,Nina Kreuzberger,Anna Lohmann,Kim Luijken,Jie Ma,Glen P. Martin,David J. McLernon,Constanza L Andaur Navarro,Johannes B. Reitsma,Jamie C. Sergeant,Chunhu Shi,Nicole Skoetz,Luc J.M. Smits,Kym I E Snell,Matthew Sperrin,René Spijker,René Spijker,Ewout W. Steyerberg,Toshihiko Takada,Ioanna Tzoulaki,Ioanna Tzoulaki,Sander M. J. van Kuijk,Bas C T van Bussel,Bas C T van Bussel,Iwan C. C. van der Horst,Florien S. van Royen,Jan Y Verbakel,Jan Y Verbakel,Christine Wallisch,Christine Wallisch,Jack Wilkinson,Robert Wolff,Lotty Hooft,Karel G.M. Moons,Maarten van Smeden +55 more
TL;DR: Proposed models for covid-19 are poorly reported, at high risk of bias, and their reported performance is probably optimistic, according to a review of published and preprint reports.
Journal ArticleDOI
Eradication of Methicillin-Resistant Staphylococcus aureus Carriage: A Systematic Review
Heidi S. M. Ammerlaan,Jan Kluytmans,Heiman F. L. Wertheim,Heiman F. L. Wertheim,Jan L. Nouwen,Marc J.M. Bonten,Marc J.M. Bonten +6 more
TL;DR: Short-term nasal application of mupirocin is the most effective treatment for eradicating methicillin-resistant S. aureus carriage, with an estimated success of rate of 90% 1 week after treatment and approximately 60% after a longer follow-up period.
Journal ArticleDOI
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design.
Derek C. Angus,Scott M. Berry,Roger J. Lewis,Farah Al-Beidh,Yaseen M. Arabi,Wilma van Bentum-Puijk,Zahra Bhimani,Marc J.M. Bonten,Kristine Broglio,Frank M. Brunkhorst,Allen C. Cheng,Jean Daniel Chiche,Menno de Jong,Michelle A. Detry,Herman Goossens,Anthony C. Gordon,Cameron Green,Alisa Higgins,Sebastiaan J. Hullegie,Peter Kruger,Francois Lamontagne,Edward Litton,John Marshall,John Marshall,Anna McGlothlin,Shay McGuinness,Shay McGuinness,Paul R Mouncey,Srinivas Murthy,Alistair Nichol,Alistair Nichol,Genevieve K. O'Neill,Rachael Parke,Rachael Parke,Jane Parker,Gernot Rohde,Kathryn M Rowan,Anne Turner,Paul J Young,Paul J Young,Lennie P. G. Derde,Lennie P. G. Derde,Colin McArthur,Colin McArthur,Steven A R Webb,Steven A R Webb,Steven A R Webb +46 more
TL;DR: A large, international trial that combines features of adaptive platform trials with pragmatic point-of-care trials to determine best treatment strategies for patients admitted to an intensive care unit with severe community-acquired pneumonia is presented.
Journal ArticleDOI
Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection.
Jan Jelrik Oosterheert,Anton M. van Loon,Rob Schuurman,Andy I. M. Hoepelman,Eelko Hak,Steven F. T. Thijsen,G.D. Nossent,M M E Schneider,Willem M N Hustinx,Marc J.M. Bonten +9 more
TL;DR: Implementation of real-time PCR for the etiological diagnosis of LRTI increased the diagnostic yield considerably, but it did not reduce antibiotic use or costs.
Journal ArticleDOI
Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force.
Stephen G. Weber,Susan S. Huang,Shannon Oriola,W. Charles Huskins,Gary A. Noskin,Kathleen Harriman,Russell N. Olmsted,Marc J.M. Bonten,Tammy Lundstrom,Michael W. Climo,Mary Claire Roghmann,Cathryn Murphy,Tobi B. Karchmer +12 more
TL;DR: Although reducing the burden of antimicrobial-resistant pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) is of preeminent importance, APIC and SHEA do not support legislation to mandate use of active surveillance cultures to screen for MRSA, VRE, or other antimicrobial -resistant pathogens.